pFUW-tetO-Irf8 Citations (2)

Originally described in: Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.
Rosa FF, Pires CF, Kurochkin I, Ferreira AG, Gomes AM, Palma LG, Shaiv K, Solanas L, Azenha C, Papatsenko D, Schulz O, Reis e Sousa C, Pereira CF Sci Immunol. 2018 Dec 7;3(30). pii: 3/30/eaau4292. doi: 10.1126/sciimmunol.aau4292. PubMed Journal

---

Articles Citing pFUW-tetO-Irf8

Articles
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses. Bayerl F, Meiser P, Donakonda S, Hirschberger A, Lacher SB, Pedde AM, Hermann CD, Elewaut A, Knolle M, Ramsauer L, Rudolph TJ, Grassmann S, Ollinger R, Kirchhammer N, Trefny M, Anton M, Wohlleber D, Hochst B, Zaremba A, Kruger A, Rad R, Obenauf AC, Schadendorf D, Zippelius A, Buchholz VR, Schraml BU, Bottcher JP. Immunity. 2023 Jun 13;56(6):1341-1358.e11. doi: 10.1016/j.immuni.2023.05.011. PubMed
Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity. Henriques-Oliveira L, Altman AR, Kurochkin I, Ascic E, Halitzki E, Matei AM, Pertiga-Cabral D, Ulmert I, Holst S, Nair MS, Cunha PP, Park SM, Vergani S, Kharas MG, Yuan J, Lahl K, Rosa FF, Pires CF, Pereira CF. Immunity. 2025 Oct 14;58(10):2419-2438.e13. doi: 10.1016/j.immuni.2025.08.001. Epub 2025 Aug 29. PubMed

If you have published an article using this material, please email us at to have your article added to this page.